Clinical Trial Update: OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of OMT-28 in Primary Mitochondrial Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Disease

Drugs mentioned

• OMT-28

Snippet

Sponsor: Omeicos Therapeutics GmbH | Conditions: Primary Mitochondrial Disease | Phase 2 | Status: COMPLETED